Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

April
09
2024

Superficial Radiotherapy: The Perfect Option for Treating Keloids

Keloids are a type of abnormal scar that appears as a raised, thickened area of skin. They form when the body produces too much collagen while healing from an injury or incision. While keloids are…

March
14
2024

Sensus Healthcare to Participate in the 36th Annual Roth Conference

Management will discuss its new “Fair Deal Agreement” for its SRT-100 Vision™ IG-SRT in one-on-one meetings in Dana Point, California on March 18th and 19th BOCA RATON, Fla., March 14, 2024 — Sensus Healthcare, Inc….

March
13
2024

Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting

New shared service contract expands the unmatched clinical results achieved with IG-SRT to a broader base of prospective customers Active traffic at the Company’s booth generated a record-high number of sales leads and affirms very…

March
06
2024

Why You Should Choose SRT to Treat Your Squamous Cell Carcinoma

Squamous cell carcinoma is a type of skin cancer that usually develops in areas of the body that are regularly exposed to the sun. While the cancer is typically slow-growing and rarely spreads to other…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy